These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphocytes in kidney transplant recipients. Yoshimura N; Kahan BD Transplantation; 1985 Dec; 40(6):661-6. PubMed ID: 3934806 [TBL] [Abstract][Full Text] [Related]
3. Immunopharmacodynamic profiles in children with renal allografts receiving cyclosporine therapy. Reisman L; Lieberman KV; Martinelli GP; Bowles KE; Schanzer H; Burrows L Am J Kidney Dis; 1988 Aug; 12(2):104-9. PubMed ID: 2969675 [TBL] [Abstract][Full Text] [Related]
4. Effect of interleukin 2 on the immunosuppressive action of cyclosporine. Hess AD Transplantation; 1985 Jan; 39(1):62-8. PubMed ID: 3155579 [TBL] [Abstract][Full Text] [Related]
5. Monitoring of cyclosporine therapy with in vitro biological assays. Lennon TP; Yee GC; Kennedy MS; Torok-Storb B; Burstein SA; Deeg HJ Transplantation; 1987 Dec; 44(6):799-804. PubMed ID: 2962343 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of human in vivo cytotoxic T lymphocyte generation by cyclosporine following organ transplantation. Keown PA; Essery-Rice G; Hellstrom A; Sinclair NR; Stiller CR Transplantation; 1985 Jul; 40(1):45-9. PubMed ID: 3892796 [TBL] [Abstract][Full Text] [Related]
7. Suppressor cell activity of cells infiltrating rat renal allografts prolonged by perioperative administration of extracted histocompatibility antigen and cyclosporine. Yoshimura N; Kahan BD Transplantation; 1985 Dec; 40(6):708-13. PubMed ID: 2933856 [TBL] [Abstract][Full Text] [Related]
8. In vitro correlates of in vivo therapy with cyclosporine to immunosuppress rejection of heterotopic rat cardiac allografts across strong (RT-1) plus weak (non-RT-1) histocompatibility differences. Miyagawa S; Stepkowski SM; Lawen JG; Rutzky LP; Kahan BD Transplantation; 1991 Nov; 52(5):851-7. PubMed ID: 1835196 [TBL] [Abstract][Full Text] [Related]
9. Development of precytotoxic T cells in cyclosporine-suppressed mixed lymphocyte reactions. Hooton JW; Miller CL; Helgason CD; Bleackley RC; Gillis S; Paetkau V J Immunol; 1990 Feb; 144(3):816-23. PubMed ID: 2136900 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of immunologic unresponsiveness induced by ultraviolet-irradiated donor-specific blood transfusions and peritransplant cyclosporine. Oluwole SF; Chabot J; Pepino P; Reemtsma K; Hardy MA Transplantation; 1988 Sep; 46(3):352-8. PubMed ID: 2971279 [TBL] [Abstract][Full Text] [Related]
11. The effects of cyclosporine and cyclosporine metabolites in experimental small intestinal transplantation. Kim PC; Cohen Z; Wong PY; Cole E; Cullen J; Skorecki K; Cheung F; Fung LS; Craig M; Levy GA Transplantation; 1990 Jun; 49(6):1043-50. PubMed ID: 2360247 [TBL] [Abstract][Full Text] [Related]
12. Immunomodulation by an adenylate cyclase activator, NKH477, in vivo and vitro. Furukawa Y; Matsumori A; Hirozane T; Matsui S; Sato Y; Ono K; Sasayama S Clin Immunol Immunopathol; 1996 Apr; 79(1):25-35. PubMed ID: 8612348 [TBL] [Abstract][Full Text] [Related]
13. Modulation of accelerated rejection of cardiac allografts in sensitized rats by anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy. Kupiec-Weglinski JW; Sablinski T; Hancock WW; Di Stefano R; Mariani G; Mix CT; Tilney NL Transplantation; 1991 Feb; 51(2):300-5. PubMed ID: 1825240 [TBL] [Abstract][Full Text] [Related]
14. Promotion of incompatible allograft acceptance in rhesus monkeys given posttransplant antithymocyte globulin and donor bone marrow. II. Effects of adjuvant immunosuppressive drugs. Thomas JM; Carver M; Cunningham P; Sash C; Park K; Thomas F Transplantation; 1989 Feb; 47(2):209-15. PubMed ID: 2645699 [TBL] [Abstract][Full Text] [Related]
15. Cyclosporine: the agent and its actions. Kahan BD Transplant Proc; 1985 Aug; 17(4 Suppl 1):5-18. PubMed ID: 3161230 [TBL] [Abstract][Full Text] [Related]
16. Mixed lymphocyte reaction-induced release of soluble IL-2 receptor. Degiannis D; Czarnecki M; Hornung N; Raskova J; Raska K Transplantation; 1991 Feb; 51(2):518-23. PubMed ID: 1825248 [TBL] [Abstract][Full Text] [Related]
17. Effect of cyclosporine, cyclosporine metabolite 17, and other cyclosporine-related compounds on T lymphocyte clones derived from rejected human kidney grafts. I. Inhibition of proliferation. Chabannes D; Moreau JF; Soulillou JP Transplantation; 1987 Dec; 44(6):813-7. PubMed ID: 3321590 [TBL] [Abstract][Full Text] [Related]
18. Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF. Hess AD; Tutschka PJ; Santos GW J Immunol; 1982 Jan; 128(1):355-9. PubMed ID: 6459374 [TBL] [Abstract][Full Text] [Related]
19. Serum cyclosporine kinetic profile. Failure to correlate with nephrotoxicity or rejection episodes following sequential immunotherapy for renal transplantation. Sommer BG; Sing DE; Henry ML; Ferguson RM; Orosz CG Transplantation; 1988 Jan; 45(1):86-90. PubMed ID: 3276069 [TBL] [Abstract][Full Text] [Related]
20. The immunobiology of experimental lung transplantation with cyclosporine immunosuppression: cytolytic T lymphocytes and delayed type hypersensitivity in rejecting and tolerant recipients. Norin AJ Transplant Proc; 1988 Apr; 20(2 Suppl 2):125-30. PubMed ID: 2966476 [No Abstract] [Full Text] [Related] [Next] [New Search]